Company intelligence / Profile preview

GC Genome

Yongin, South Koreagc-genome.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

GC Genome is a leading South Korean clinical genomics and diagnostics company offering CAP-accredited laboratory services. It specializes in next-generation sequencing-based tests for oncology, rare diseases, prenatal/neonatal screening, and health check-ups. The company has launched several proprietary products including AI-driven multi-cancer early detection tests ("AI-CANCERCH"), personalized health management panels ("GeneSketch"), miscarriage analysis panels ("M-screen"), and microbiome testing. Recent research has been presented at major international conferences such as ASCO, AACR, ESMO; peer-reviewed results include publications in Nature Communications.

Therapeutic areas
OncologyWomen's HealthRare DiseasesOther
Modalities
Diagnostic testIn vitro diagnostic device (IVD)
Industry
Molecular Diagnostics
02

Drug pipeline

1 asset

ai-CANCERCH

Commercial
Indications
Lung cancer, Liver cancer, Colorectal cancer, Pancreatic cancer, Esophageal cancer, Ovarian cancer
03

Partnerships

Genece Health (USA) – licensing agreement for liquid biopsy core technologyMultiple national hospitals/universities in South KoreaGlobal partners across Asia/Middle East/America/Europe

Beyond the preview

Go deeper on GC Genome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GC Genome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call